ONCOMATRYX BIOPHARMA, S.A.
Contact information
ONCOMATRYX BIOPHARMA, S.A.
Pedro Esnaola - CPAO
Parque Tecnológico Bizkaia 801B 2P
Derio - 48160
Bizkaia
+34 946 087 037
Areas of activities
- Biodrugs
- Biomarkers
- Drug development
- Drug discovery
- Immunology
- Oncology
Commissions
Oncomatryx is a clinical-stage biotech company developing ADCs against the tumour microenvironment to bring therapeutic alternatives to metastatic solid tumour patients.
Products and services
OMTX705- FAP targeting ADC. Currently in phase 1b/2a clinical trials for 4 lead indications: PDAC, MSS-CRC, NSCLC and sarcoma. Oncomatryx also has a next-generation ADC pipeline, with a variety of tumor microenvironment targets, payloads and linkers.
Areas of interest for future collaborations
Looking for out-licensing of OMTX705 to a mid-large pharmaceutical company.